Tepco, Mitsubishi Plan Coal-Fired Power Plants At Fukushima

The operator of Japan's wrecked nuclear plant and three Mitsubishi group firms plan to build a new type of energy-efficient coal-fired power plant in Fukushima, a source said on Saturday.

Tokyo Electric Power Co will tie up with Mitsubishi Heavy Industries, Mitsubishi Corp and Mitsubishi Electric to build integrated gasification combined-cycle (IGCC) stations.

Mitsubishi group companies will have a majority stake in the new plants while cash-strapped Tepco will be in charge of running the facilities, which they plan to put online around 2020, the source said.

Tepco has been under pressure to introduce energy-efficient facilities as all of its nuclear power plants have been closed in the wake of the Fukushima disaster, with no immediate prospects of restarting any nuclear plants given public distrust.

Mitsubishi Heavy also aims to be a leading player in the new IGCC technology, which will increase power output by 20% from conventional coal power plants, using the same amount of fuel.

Three reactors suffered core meltdowns at the Fukushima Daiichi plant north of Tokyo after the March 2011 earthquake and tsunami that triggered explosions and forced the evacuation of 160,000 people from nearby towns and villages.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read